The U.S. Is Betting $117 Million on Wearables That Track Hormones, Drugs and Inflammation

ARPA-H has funded four very different biosensor designs, but its own timetable puts the first in-vivo prototype no earlier than month 24.

ARPA-H has funded four very different biosensor designs, but its own timetable puts the first in-vivo prototype no earlier than month 24.

Novo Nordisk has confirmed that a cyberattack resulted in the theft of clinical trial participant data, although the information was pseudonymized and not directly linked to individuals.
Beacon Biosignals is pioneering a new approach to understanding brain function by monitoring sleep patterns with an AI-driven platform designed for home use.